- Nachrichtendetail
-
24.04.2024 16:26:17 - dpa-AFX: *IMMUTEP: PHASE IIB TRIAL SHOWS POSITIVE RESULTS IN FIRST-LINE HNSCC TREATMENT WITH EFTILAGIMOD ALPHA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
MERCK CO. DL-,01 | A0YD8Q | Xetra | 119,800 | 15.05.24 12:22:08 | +1,200 | +1,01% | 119,200 | 120,000 | 119,400 | 118,600 |
